Assyro AI

Orange Book product · Brand (NDA)

INCIVEK

TELAPREVIR

Brand (NDA)NDA 201917DISCN VERTEX PHARMS

At a glance

May 23, 2011

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 23, 2011

    15 yr 4 mo ago

  2. Today

  3. Patent 8431615 expires

    Listed method-of-use patent (U-1398) expiration.

    May 30, 2028

    in 2 yr

Pharmaceutical detail

Active ingredient

TELAPREVIR

Strength

375MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 201917

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8431615May 30, 2028in 2 yr
U-1398
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.